TherapeuticsMD Inc

TXMDNASDAQ · USD
2.18USD0.00 (0.00%)
6110

TherapeuticsMD Inc (TXMD) Expected Move

TXMD expected move through Sep 18, 2026 is 82.0%, with 0 days to expiration. The implied range is $0.39 to $3.97, based on the previous trading day's options prices.

Read more

Tracking the TXMD expected move helps you see how far TherapeuticsMD Inc's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. TherapeuticsMD Inc's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the TXMD expected move for this week's options, in real time.

The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For TXMD, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The TXMD expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks TherapeuticsMD Inc is unlikely to go.

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation.

It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the TXMD expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The TherapeuticsMD Inc expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about TXMD.

TXMD Price

EARN
EM

Drag chart to pan. Drag axes to zoom.

ExpirationDTEExpected move (USD)Expected move (%)Upper priceLower price
Sep 18, 20260$1.7982.0%$3.97$0.39
Oct 16, 202628$1.5671.7%$3.74$0.62
Nov 20, 202663$14.35658.3%$16.53-$12.17
Dec 18, 202691$1.0949.9%$3.27$1.09

As of September 17, 2026

Know What the Market Expects From TXMD

Track the TXMD expected move across every expiration, filter by IV rank and liquidity, and trade around the range the market is already pricing in.

Start your 14-day free trial